Ignite Creation Date:
2024-05-05 @ 6:51 PM
Last Modification Date:
2024-10-26 @ 9:37 AM
Study NCT ID:
NCT00551408
Status:
COMPLETED
Last Update Posted:
2018-10-16
First Post:
2007-10-29
Brief Title:
Endothelial Progenitor Cells and Pulmonary Idiopathic Arterial Hypertension
Sponsor:
Unidad de Investigacion Clinica en Medicina SC
Organization:
Unidad de Investigacion Clinica en Medicina SC
Study Overview
Official Title:
The Determination of Endothelial Progenitor Cells in Pulmonary Idiopathic Arterial Hypertension
Status:
COMPLETED
Status Verified Date:
2018-10
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
Endothelial dysfunction ultimately represents an imbalance between the magnitude of injury and the capacity for repair
Current evidence established that endothelial progenitor cells EPC participate in several models of vascular disease as acute coronary syndromes stroke diabetes peripheral artery disease etc However EPC in the setting of PAH is less well established The target of this study is to demonstrate if the number of EPC is increased in a mexican population of patients with PAH
Current evidence established that endothelial progenitor cells EPC participate in several models of vascular disease as acute coronary syndromes stroke diabetes peripheral artery disease etc However EPC in the setting of PAH is less well established The target of this study is to demonstrate if the number of EPC is increased in a mexican population of patients with PAH
Detailed Description:
None
Study Oversight
Has Oversight DMC:
None
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?:
None
Secondary IDs
| Secondary ID | Type | Domain | Link |
|---|---|---|---|
| 07-012 | None | None | None |